OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation […]

  • Related Posts

    Grok says it’s ‘skeptical’ about Holocaust death toll, then blames ‘programming error’

    Grok, the AI-powered chatbot created by xAI and widely deployed across its new corporate sibling X, wasn’t just obsessed with white genocide this week. As first noted in Rolling Stone,…

    Continue reading
    U.S. lawmakers have concerns about Apple-Alibaba deal

    The Trump administration and congressional officials are scrutinizing a deal between Apple and Alibaba that would bring Alibaba-powered AI features to iPhones sold in China, according to The New York…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Grok says it’s ‘skeptical’ about Holocaust death toll, then blames ‘programming error’

    • By staff
    • May 18, 2025
    • 1 views

    U.S. lawmakers have concerns about Apple-Alibaba deal

    • By staff
    • May 18, 2025
    • 1 views

    Microsoft’s Satya Nadella is choosing chatbots over podcasts

    • By staff
    • May 17, 2025
    • 2 views

    MIT disavows doctoral student paper on AI’s productivity benefits

    • By staff
    • May 17, 2025
    • 2 views